Low-grade Infections of the Intervertebral Discs

January 13, 2021 updated by: Kepler University Hospital

Frequency and Characteristics of Low-grade Infections of the Intervertebral Discs

The purpose of this prospective, observational study was to evaluate frequency and characteristics of low-grade infections of the intervertebral discs in an unselected real-life patient population undergoing surgery for degenerative pathologies of the spine.

Study Overview

Detailed Description

Low-grade infection of the intervertebral discs, causing disc degeneration and consecutive pain and disability is reported in literature. Microorganisms are also held responsible for Modic Changes of the vertebral bodies.

Patients underwent surgery for degenerative pathology of the spine independent of this study. After being informed about this study, all patients giving written informed consent who met eligibility requirements were included. Treatment of the patients was independent of this study. Intraoperative removed disc tissue was examined using microbiological culture, viral polymerase chain reaction (PCR), and histopathological analysis.

Other used data were demographic data (Gender, age), Modic Changes on MRI, preoperative Oswestry Disability Index (ODI), preoperative Neck Disability Index (NDI), and preoperative C-reactive protein (CRP).

Frequency of positive microbiological culture findings, viral PCR, and inflammation signs in histopathological analysis was described, and statistical analysis was performed to identify if any of the above mentioned parameters influences the frequency of positive microbiological culture and Modic Changes significant.

Study Type

Observational

Enrollment (Actual)

392

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Upper Austria
      • Linz, Upper Austria, Austria, 4020
        • Department of Neurosurgery, Kepler University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Tertiary referral center

Description

Inclusion Criteria:

  • Spine surgery including discectomy due to degenerative diseases
  • Availability of removed disc tissue for further analysis

Exclusion Criteria:

  • Signs of spondylodiscitis (clinical signs, inflammation parameters, radiological)
  • Suspected or known tumor disease
  • Traumatic fractures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Routine discectomy
Patients undergoing routine spine surgery due to degenerative disease of the spine

Intervertebral disc tissue was sent to the laboratory for further analysis:

Microbiological culture: Detection of bacterial growth Viral PCR: Detection of Herpes-Simplex-Type 1 virus, Herpes-Simplex-Type 2 virus, Cytomegalovirus Histopathological analysis: Inflammation signs of disc tissue

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bacterial growth
Time Frame: 1 week (Time from surgery until final result of microbiological culture was available)
Number of intervertebral discs with at least one positive microbiological culture result
1 week (Time from surgery until final result of microbiological culture was available)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HSV-1
Time Frame: 1 week (Time from surgery until final result of PCR was available)
Number of intervertebral discs with at least one positive result for Herpes-Simplex-Virus type 1
1 week (Time from surgery until final result of PCR was available)
HSV-2
Time Frame: 1 week (Time from surgery until final result of PCR was available)
Number of intervertebral discs with at least one positive result for Herpes-Simplex-Virus type 2
1 week (Time from surgery until final result of PCR was available)
CMV
Time Frame: 1 week (Time from surgery until final result of PCR was available)
Number of intervertebral discs with at least one positive result for Cytomegalovirus
1 week (Time from surgery until final result of PCR was available)
MC 1
Time Frame: Measured on preoperative MRI (maximum 3 months old)
Positive Modic Change type 1 in the operated segment
Measured on preoperative MRI (maximum 3 months old)
MC 2
Time Frame: Measured on preoperative MRI (maximum 3 months old)
Positive Modic Change type 2 in the operated segment
Measured on preoperative MRI (maximum 3 months old)
MC 3
Time Frame: Measured on preoperative MRI (maximum 3 months old)
Positive Modic Change type 2 in the operated segment
Measured on preoperative MRI (maximum 3 months old)
ODI
Time Frame: Measured preoperative at hospital admission, i.e. 1-3 days before operation
Oswestry Disability Index, measured only in case of lumbar spine surgery
Measured preoperative at hospital admission, i.e. 1-3 days before operation
NDI
Time Frame: Measured preoperative at hospital admission, i.e. 1-3 days before operation
Neck Disability Index, measured only in case of cervical spine surgery
Measured preoperative at hospital admission, i.e. 1-3 days before operation
CRP
Time Frame: Measured preoperative at hospital admission, i.e. 1-3 days before operation
C-reactive protein in mg/dl, measured as blood sample
Measured preoperative at hospital admission, i.e. 1-3 days before operation
Pathology
Time Frame: 1 week (Time from surgery until final result of histopathological analyzsis was available)
Positive inflammation signs in histopathological analysis. Analyzed for each collected intervertebral disc
1 week (Time from surgery until final result of histopathological analyzsis was available)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wolfgang Senker, MD, Kepler University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2018

Primary Completion (ACTUAL)

January 31, 2020

Study Completion (ACTUAL)

October 31, 2020

Study Registration Dates

First Submitted

January 13, 2021

First Submitted That Met QC Criteria

January 13, 2021

First Posted (ACTUAL)

January 15, 2021

Study Record Updates

Last Update Posted (ACTUAL)

January 15, 2021

Last Update Submitted That Met QC Criteria

January 13, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disc Degeneration

Clinical Trials on Microbiological culture, viral PCR, histopathological analysis

Subscribe